ETView Medical to distribute VivaSight airway devices ETView Medical Ltd.

Amphar, ETView Medical to distribute VivaSight airway devices ETView Medical Ltd. announced today that it provides entered into a distribution agreement with Amphar b.v . . William Edelman, CEO of ETView Medical commented, We are excited to add Amphar to our expanding distributor network. Mr. On 20 February, 2012, ETView announced an exclusive license agreement for just two US patents with James S. Simon, M.D. On February 7, february 2 and, 2012, ETView announced distribution agreements with NeuroMed Ltd. a surgical products sales and distribution organization located in St. Petersburg, Russia, and State of the Art Medical Items, Inc., a specialty surgical products distribution and sales company, based in Cedar Grove, NJ.

common info

America’s first two WNV encephalitis cases of 2004 respond to treatment GenoMed, Inc. Has announced that the country’s second case of West Nile virus encephalitis offers responded promptly to its treatment approach. Up to now, GenoMed’s treatment is displaying a 100 percent response price among 13 immunocompetent patients. The sooner the treatment is instituted, the faster and more comprehensive the response. The initial case involved a 79 year old guy treated in Portsmouth, Ohio. The most recent case involves a 67 year old man from Marion, Arkansas. Why is this case specifically interesting is that gentleman was immunosuppressed until only a few days before receiving GenoMed’s treatment. He took 30 mg of Prednisone for 11 years due to arthritis, before his physicians could actually wean his Prednisone dose right down to 5 mg a complete day.